Chiu-Chuan S Lin

Title: The Innovative Contributions of Chiu-Chuan S Lin

Introduction

Chiu-Chuan S Lin is a notable inventor based in Holmdel, NJ (US). He has made significant contributions to the field of immunology through his research and innovations. His work primarily focuses on the development of peptides with immunosuppressant activity, which have important applications in medicine.

Latest Patents

Chiu-Chuan S Lin holds a patent for the Scorpion peptide margatoxin, which is a thirty-nine amino acid peptide purified from the venom of the scorpion Centruroides margaritatus. The gene encoding margatoxin (MgTX) has been constructed and expressed in E. coli to produce recombinant MgTX. This peptide acts as a potent and selective inhibitor of a voltage-dependent K⁺ channel present in human lymphocytes. MgTX exhibits immunosuppressant activity with human T-lymphocytes, making it useful in treating autoimmune diseases and preventing the rejection of foreign organ transplants.

Career Highlights

Chiu-Chuan S Lin is currently employed at Merck & Co., Inc., where he continues to advance his research in immunology and peptide development. His work has the potential to lead to new therapies for various diseases and conditions.

Collaborations

Some of his notable coworkers include Maria L Garcia and Gloria C Koo, who contribute to the collaborative efforts in research and development at Merck & Co., Inc.

Conclusion

Chiu-Chuan S Lin's innovative work in the field of immunology, particularly with the development of margatoxin, showcases the importance of research in creating effective treatments for autoimmune diseases and organ transplant rejection. His contributions are paving the way for future advancements in medical science.